Jin RC, Mahoney CE, Coleman Anderson L, Ottaviano F, Croce K, Leopold JA, Zhang YY, Tang SS, Handy DE, Loscalzo J
Drug evaluation: Vildagliptin-metformin single-tablet combination
240 Capsules, Each With 500mg of L-Carnitine Tartrate 1000mg Per Serving & 120 Servings Per Bottle No Harmful Additives Non-GMO and Gluten Free Manufactured In a NSF Certified, GMP Compliant, FDA Registered Facility
The product contains 68.0% L-Carnitine content and 31.7% L-Tartaric acid content, demonstrating excellent purity
While these findings provide preliminary evidence of the potential benefit of semaglutide in CUD in real-world populations further preclinical studies are warranted to understand the underlying mechanism and randomized clinical trials are needed to support its use clinically for CUD
G.TandlerB.HoppelC